These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6721884)

  • 1. Costs and outcomes in rheumatoid arthritis and osteoarthritis.
    Liang MH; Larson M; Thompson M; Eaton H; McNamara E; Katz R; Taylor J
    Arthritis Rheum; 1984 May; 27(5):522-9. PubMed ID: 6721884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
    Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
    J Rheumatol; 1997 Jan; 24(1):43-8. PubMed ID: 9002009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs.
    Lanes SF; Lanza LL; Radensky PW; Yood RA; Meenan RF; Walker AM; Dreyer NA
    Arthritis Rheum; 1997 Aug; 40(8):1475-81. PubMed ID: 9259428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
    Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
    Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs related to rheumatoid arthritis: the patient perspective.
    Hülsemann JL; Mittendorf T; Merkesdal S; Handelmann S; von der Schulenburg JM; Zeidler H; Ruof J
    Ann Rheum Dis; 2005 Oct; 64(10):1456-61. PubMed ID: 15800007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter study of annual health service utilization and costs in rheumatoid arthritis.
    Lubeck DP; Spitz PW; Fries JF; Wolfe F; Mitchell DM; Roth SH
    Arthritis Rheum; 1986 Apr; 29(4):488-93. PubMed ID: 3707626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "The Financial Impact Is Depressing and Anxiety Inducing": A Qualitative Exploration of the Personal Financial Toll of Arthritis.
    Berkovic D; Ayton D; Briggs AM; Ackerman IN
    Arthritis Care Res (Hoboken); 2021 May; 73(5):671-679. PubMed ID: 32100969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H; Luan L; Yang K; Li SC
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study.
    Maetzel A; Li LC; Pencharz J; Tomlinson G; Bombardier C;
    Ann Rheum Dis; 2004 Apr; 63(4):395-401. PubMed ID: 15020333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of rheumatoid arthritis: facts and figures.
    Callahan LF
    J Rheumatol Suppl; 1998 Jul; 53():8-12. PubMed ID: 9666412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
    J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for standardization: a literature review of indirect costs of rheumatoid arthritis and osteoarthritis.
    Xie F
    Arthritis Rheum; 2008 Jul; 59(7):1027-33. PubMed ID: 18576305
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.
    Clarke AE; Zowall H; Levinton C; Assimakopoulos H; Sibley JT; Haga M; Shiroky J; Neville C; Lubeck DP; Grover SA; Esdaile JM
    J Rheumatol; 1997 Jun; 24(6):1051-60. PubMed ID: 9195508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).
    Hallert E; Husberg M; Skogh T
    Rheumatology (Oxford); 2006 Mar; 45(3):325-31. PubMed ID: 16287927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct medical costs unique to people with arthritis.
    Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
    J Rheumatol; 1997 Apr; 24(4):719-25. PubMed ID: 9101508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid prescription formulary restrictions and arthritis treatment costs.
    Johnson TJ; Stahl-Moncada S
    Am J Public Health; 2008 Jul; 98(7):1300-5. PubMed ID: 18511729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure.
    Cross MJ; March LM; Lapsley HM; Byrne E; Brooks PM
    Rheumatology (Oxford); 2006 Jan; 45(1):92-6. PubMed ID: 16287930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 28-Joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project.
    Hallert E; Husberg M; Skogh T
    Rheumatology (Oxford); 2011 Jul; 50(7):1259-67. PubMed ID: 21292734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.